TITLE

Noteworthy

PUB. DATE
March 2008
SOURCE
Pharmaceutical Representative;Mar2008, Vol. 38 Issue 3, p13
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on various medical research. It presents a study of elderly male participants, which assesses the relationship between individuals' scores on four measures of anxiety and incidence of myocardial infarction. It also cites a survey which identifies the therapeutic use of placebos, and a study that debunks several medical myths.
ACCESSION #
31184194

 

Related Articles

  • ACCOAST-PCI: Prasugrel pretreatment no benefit in non-STEMI patients undergoing PCI. Ellis, Brian // Cardiology Today;Jul2014, Vol. 17 Issue 7, p14 

    The article reports on the ACCOAST-PCI study which revealed that prasurgel pre-treatment compared with placebo in non-ST-segment elevation myocardial infarction (STEMI) patients did not decrease thrombus burden but was associated with significant risk for major bleeding.

  • One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Hansteen, V.; Moinichen, E.; Lorentsen, E.; Strom, O.; Soiland, K.; Dyrbekk, D.; Refsum, A.-M.; Tromsdal, A.; Knudsen, K.; Eika, C.; Jun, J. Bakken; Smith, P.; Hoff, P.I. // British Medical Journal (Clinical Research Edition);1/16/1982, Vol. 284 Issue 6310, p155 

    Investigates the effects of propranolol and placebo on patients with history of myocardial infarction in Norway. Rate of mortality; Reduction in sudden cardiac deaths among high risk patients treated with propanol; Benefits of long-term beta-adrenoceptor blockade in low-risk patients.

  • Fondaparinux reduced death or reinfarction in acute ST-segment elevation myocardial infarction.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p29 

    The article presents information on the method adopted to treat patients with acute ST-segment elevation myocardial infarction. The objective was to find out the effect of the drug fondaparinux in reducing reinfarction or death in patients. Randomized placebo-controlled trial was carried out on...

  • Amlodipine plus atorvastatin demonstrates potentially synergistic cardioprotective effects in ASCOT--LLA. Sever, P.; Dahlöf, B.; Poulter, N. // Formulary;Jan2007, Vol. 42 Issue 1, p39 

    The article presents a study on the effects of synergistic cardioprotective interaction between amlodipine and atorvastatin in patients from Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA). The study suggests that patients receiving amlodipine-based regimens experienced...

  • Psychiatry and Medicine in Transition. Fawcett, Jan // Psychiatric Annals;Feb2014, Vol. 44 Issue 2, p66 

    An introduction is presented in which the editor discusses various reports within the issue on topics including studies on the placebo response, the transition of psychiatry and medicine, and a discussion on medications on anxiety and psychosis by doctor Devdut Nayak.

  • Long term propranolol treatment and changes in body weight after myocardial infarction. Rossner, Stephen; Taylor, Carol L.; Byington, Robert P.; Furberg, Curt D. // BMJ: British Medical Journal (International Edition);4/7/90, Vol. 300 Issue 6729, p902 

    Examines the effect of long term propranol treatment and changes in the body weight after myocardial infarction. Analysis of placebo controlled data; Changes in the body weight; Implication in diuretics or physical activity.

  • Review: Rosiglitazone increase risk for MI but does not differ from other drugs for CV death in type 2 diabetes.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p66 

    The article offers information on a study analyzing the effects of rosiglitazone (RGZ) on risk of myocardial infarction (MI) and cardiovascular (CV) deaths. It mentions several data sources used in the study including the U.S. Food and Drug Administration web site. It discusses the selection and...

  • A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials. Simes, John; Voysey, Merryn; O'Connell, Rachel; Glasziou, Paul; Best, James D.; Scott, Russell; Pardy, Christopher; Byth, Karen; Sullivan, David R.; Ehnholm, Christian; Keech, Anthony // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    Background: When rates of uptake of other drugs differ between treatment arms in long-term trials, the true benefit or harm of the treatment may be underestimated. Methods to allow for such contamination have often been limited by failing to preserve the randomization comparisons. In the...

  • Tonsils and appendix surgery linked to youth MI.  // Pulse;6/8/2011, Vol. 71 Issue 21, p9 

    The article reports on the result of a study which revealed that children and teenagers who have their tonsils and appendix removed have high risk of early heart attack.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics